BRIDGEWAY CAPITAL MANAGEMENT, LLC - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 53 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 1.8%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$226,220
-7.3%
147,8560.0%0.01%
-16.7%
Q2 2023$243,962
+49.7%
147,856
+3.4%
0.01%
+50.0%
Q1 2023$162,970
+26.4%
142,9560.0%0.00%
+33.3%
Q4 2022$128,961
-22.8%
142,9560.0%0.00%
-25.0%
Q3 2022$167,000
+27.5%
142,956
-30.0%
0.00%
+33.3%
Q2 2022$131,000
-81.3%
204,356
-23.9%
0.00%
-78.6%
Q1 2022$701,000
-1.5%
268,556
+46.8%
0.01%
+7.7%
Q4 2021$712,000
-10.8%
183,0000.0%0.01%
-13.3%
Q3 2021$798,000
+58.3%
183,000
+44.1%
0.02%
+66.7%
Q2 2021$504,000
-36.2%
127,000
-16.4%
0.01%
-40.0%
Q1 2021$790,000
-2.8%
152,0000.0%0.02%
-11.8%
Q4 2020$813,000
+40.9%
152,000
+27.8%
0.02%
+30.8%
Q3 2020$577,000
+47.6%
118,900
+47.7%
0.01%
+62.5%
Q2 2020$391,000
+122.2%
80,5000.0%0.01%
+100.0%
Q1 2020$176,000
-59.7%
80,500
+7.3%
0.00%
-33.3%
Q4 2019$437,000
+128.8%
75,000
+25.0%
0.01%
+100.0%
Q3 2019$191,000
-24.2%
60,0000.0%0.00%0.0%
Q2 2019$252,000
-62.4%
60,000
-38.1%
0.00%
-62.5%
Q1 2019$670,00097,0000.01%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$16,188,081100.00%
Vahanian & Associates Financial Planning Inc. 725,208$1,196,5933.78%
Bracebridge Capital, LLC 428,571$707,1420.39%
Latash Investments, LLC 243,134$401,1710.32%
XTX Topco Ltd 138,145$227,9390.04%
ARMISTICE CAPITAL, LLC 1,158,000$1,910,7000.03%
OCCUDO QUANTITATIVE STRATEGIES LP 84,355$139,1860.01%
Hillsdale Investment Management Inc. 66,600$109,8900.01%
D.B. Root & Company, LLC 12,950$21,3680.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 147,856$243,9620.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders